An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing Surveillance

Publisher： IGI Global_journal

E-ISSN： 1555-340x|2|3|65-80

ISSN： 1555-3396

Source： International Journal of Healthcare Information Systems and Informatics (IJHISI), Vol.2, Iss.3, 2007-07, pp. : 65-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liver injury with novel oral anticoagulants: assessing post‐marketing reports in the US Food and Drug Administration adverse event reporting system

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 2, 2015-08 ,pp. : 285-293

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transdermal buprenorphine in clinical practice – a post-marketing surveillance study in 13 179 patients

By Griessinger Norbert   Sittl Reinhard   Likar Rudolf  

Current Medical Research and Opinion, Vol. 21, Iss. 8, 2005-08 ,pp. : 1147-1156

Informa Healthcare

Access to resources Recommend Favorite

Slow-Release Oral Morphine Sulfate Abuse: Results of the Postmarketing Surveillance Systems for Psychoactive Prescription Drug Abuse in France

By  

European Addiction Research, Vol. 19, Iss. 5, 2013-02 ,pp. : 235-244

Karger

Access to resources Recommend Favorite

Off‐label use of nicardipine as tocolytic and acute pulmonary oedema: a post‐marketing analysis of adverse drug reaction reports in EudraVigilance

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 11, 2015-11 ,pp. : 1220-1224

John Wiley & Sons Inc

Access to resources Recommend Favorite

Enhancing postmarketing surveillance: continuing challenges

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 306-5251, Iss. 4, 2015-10 ,pp. : 615-617

John Wiley & Sons Inc

Access to resources Recommend Favorite